Maternal serum PlGF (placental growth factor) in Chinese women in the first trimester undergoing screening for Down syndrome.

[1]  Tianhua Huang,et al.  First trimester screening for Down syndrome using nuchal translucency, maternal serum pregnancy‐associated plasma protein A, free‐β human chorionic gonadotrophin, placental growth factor, and α‐fetoprotein , 2015, Prenatal diagnosis.

[2]  U. Stenman,et al.  Serum hyperglycosylated human chorionic gonadotrophin at 14–17 weeks of gestation does not predict preeclampsia , 2014, Prenatal diagnosis.

[3]  H. Cuckle,et al.  First-trimester Down syndrome screening using additional serum markers with and without nuchal translucency and cell-free DNA. , 2013, Prenatal diagnosis.

[4]  H. Cuckle,et al.  Maternal serum placental growth factor and α‐fetoprotein testing in first trimester screening for Down syndrome , 2013, Prenatal diagnosis.

[5]  H. Abele,et al.  First‐trimester combined screening for trisomy 21 with different combinations of placental growth factor, free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐A , 2012, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[6]  I. Herraiz,et al.  Re: First‐trimester combined screening for trisomy 21 with different combinations of placental growth factor, free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐A. K. O. Kagan, M. Hoopmann, H. Abele, R. Alkier and K. Lüthgens. Ultrasound Obstet Gynecol 2012; 40: 530–535 , 2012, Ultrasound in Obstetrics and Gynecology.

[7]  D. Wright,et al.  Maternal Serum Placental Growth Factor in Prospective Screening for Aneuploidies at 8–13 Weeks’ Gestation , 2012, Fetal Diagnosis and Therapy.

[8]  D. Sahota,et al.  Serum placental growth factor and fms-like tyrosine kinase 1 during first trimester in Chinese women with pre-eclampsia – a case–control study , 2011, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[9]  K. Spencer,et al.  Early first‐trimester maternal serum placental growth factor in trisomy 21 pregnancies , 2011, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[10]  H. Cuckle.  Screening for pre-eclampsia--lessons from aneuploidy screening. , 2011, Placenta.

[11]  D. Sahota,et al.  Maternal serum ADAM12 in Chinese women undergoing screening for aneuploidy in the first trimester , 2010, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[12]  D. Sahota,et al.  Medians and correction factors for biochemical and ultrasound markers in Chinese women undergoing first‐trimester screening for trisomy 21 , 2009, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[13]  K. Nicolaides,et al.  Maternal serum placental growth factor at 11–13 weeks in chromosomally abnormal pregnancies , 2009, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[14]  K. Nicolaides,et al.  Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11+0 to 13+6 weeks of gestation , 2008, Prenatal diagnosis.

[15]  D. Wright,et al.  First‐trimester screening for trisomy 21 by free beta‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐A: impact of maternal and pregnancy characteristics , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[16]  K. Spencer,et al.  Higher Median Levels of Free β-hCG and PAPP-A in the First Trimester of Pregnancy in a Chinese Ethnic Group , 2005, Fetal Diagnosis and Therapy.

[17]  K. Spencer,et al.  Age‐standardisation when target setting and auditing performance of Down syndrome screening programmes , 2004, Prenatal diagnosis.

[18]  T. Spector,et al.  Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies , 2004, The New England journal of medicine.

[19]  N. Bersinger,et al.  Second‐ and third‐trimester serum levels of placental proteins in preeclampsia and small‐for‐gestational age pregnancies , 2004, Acta obstetricia et gynecologica Scandinavica.

[20]  S. Aydin,et al.  Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels , 2003, Acta obstetricia et gynecologica Scandinavica.

[21]  T. H. Wang,et al.  Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. , 1997, Placenta.

[22]  N J Wald,et al.  Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alphafetoprotein level , 1988, British journal of obstetrics and gynaecology.

[23]  H. Cuckle,et al.  Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha‐fetoprotein level , 1987, British journal of obstetrics and gynaecology.

[24]  K. Spencer,et al.  Higher median levels of free beta-hCG and PAPP-A in the first trimester of pregnancy in a Chinese ethnic group. Implication for first trimester combined screening for Down's syndrome in the Chinese population. , 2006, Fetal diagnosis and therapy.

[25]  H. Weich,et al.  A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta. , 1993, Growth factors.

[26]  P. Royston,et al.  Model-based screening by risk with application to Down's syndrome. , 1992, Statistics in medicine.